144 related articles for article (PubMed ID: 2959375)
1. Augmentation of transfer of experimental autoimmune thyroiditis (EAT) in mice by irradiation of recipients.
Williams WV; Kyriakos M; Sharp GC; Braley-Mullen H
Cell Immunol; 1987 Oct; 109(2):397-406. PubMed ID: 2959375
[TBL] [Abstract][Full Text] [Related]
2. The role of cellular proliferation in the induction of experimental autoimmune thyroiditis (EAT) in mice.
Williams WV; Kyriakos M; Sharp GC; Braley-Mullen H
Cell Immunol; 1986 Nov; 103(1):96-104. PubMed ID: 3802208
[TBL] [Abstract][Full Text] [Related]
3. The cellular basis for the Ia restriction in murine experimental autoimmune thyroiditis.
Williams WV; Kyriakos M; Sharp GC; Braley-Mullen H
Cell Immunol; 1987 Nov; 110(1):35-45. PubMed ID: 3499988
[TBL] [Abstract][Full Text] [Related]
4. Induction of experimental autoimmune thyroiditis in mice with in vitro activated splenic T cells.
Braley-Mullen H; Johnson M; Sharp GC; Kyriakos M
Cell Immunol; 1985 Jun; 93(1):132-43. PubMed ID: 3873286
[TBL] [Abstract][Full Text] [Related]
5. CD40L is necessary for the priming of effector cells for lymphocytic and granulomatous experimental autoimmune thyroiditis.
Peterson KE; Braley-Mullen H
J Autoimmun; 1999 Feb; 12(1):1-12. PubMed ID: 10028017
[TBL] [Abstract][Full Text] [Related]
6. Induction of granulomatous experimental autoimmune thyroiditis in mice with in vitro activated effector T cells and anti-IFN-gamma antibody.
Stull SJ; Sharp GC; Kyriakos M; Bickel JT; Braley-Mullen H
J Immunol; 1992 Sep; 149(6):2219-26. PubMed ID: 1517579
[TBL] [Abstract][Full Text] [Related]
7. Effects of the adjuvants SGP and Quil A on the induction of experimental autoimmune thyroiditis in mice.
Williams WV; Kyriakos M; Sharp GC; Braley-Mullen H
Cell Immunol; 1987 Feb; 104(2):296-303. PubMed ID: 3815534
[TBL] [Abstract][Full Text] [Related]
8. Induction of severe granulomatous experimental autoimmune thyroiditis in mice by effector cells activated in the presence of anti-interleukin 2 receptor antibody.
Braley-Mullen H; Sharp GC; Bickel JT; Kyriakos M
J Exp Med; 1991 Apr; 173(4):899-912. PubMed ID: 1672546
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the induction and resolution of granulomatous experimental autoimmune thyroiditis in mice by CD8+ T cells.
Braley-Mullen H; McMurray RW; Sharp GC; Kyriakos M
Cell Immunol; 1994 Feb; 153(2):492-504. PubMed ID: 8118878
[TBL] [Abstract][Full Text] [Related]
10. A thyroxine-containing thyroglobulin peptide induces both lymphocytic and granulomatous forms of experimental autoimmune thyroiditis.
Braley-Mullen H; Sharp GC
J Autoimmun; 1997 Dec; 10(6):531-40. PubMed ID: 9451592
[TBL] [Abstract][Full Text] [Related]
11. B7.2 has opposing roles during the activation versus effector stages of experimental autoimmune thyroiditis.
Peterson KE; Sharp GC; Tang H; Braley-Mullen H
J Immunol; 1999 Feb; 162(3):1859-67. PubMed ID: 9973452
[TBL] [Abstract][Full Text] [Related]
12. Intravenous administration of deaggregated mouse thyroglobulin suppresses induction of experimental autoimmune thyroiditis and expression of both Th1 and Th2 cytokines.
Tang H; Braley-Mullen H
Int Immunol; 1997 May; 9(5):679-87. PubMed ID: 9184913
[TBL] [Abstract][Full Text] [Related]
13. Differential requirement for autoantibody-producing B cells for induction of lymphocytic versus granulomatous experimental autoimmune thyroiditis.
Braley-Mullen H; Sharp GC; Kyriakos M
J Immunol; 1994 Jan; 152(1):307-14. PubMed ID: 8254200
[TBL] [Abstract][Full Text] [Related]
14. Prevention and reversal of experimental autoimmune thyroiditis (EAT) in mice by administration of anti-L3T4 monoclonal antibody at different stages of disease development.
Stull SJ; Kyriakos M; Sharp GC; Braley-Mullen H
Cell Immunol; 1988 Nov; 117(1):188-98. PubMed ID: 2902931
[TBL] [Abstract][Full Text] [Related]
15. Activation of cytotoxic T cells and effector cells in experimental autoimmune thyroiditis by shared determinants of mouse and human thyroglobulins.
Simon LL; Justen JM; Giraldo AA; Krco CJ; Kong YC
Clin Immunol Immunopathol; 1986 May; 39(2):345-56. PubMed ID: 2421954
[TBL] [Abstract][Full Text] [Related]
16. Distinctive modulation by IL-4 and IL-10 of the effector function of murine thyroglobulin-primed cells in "transfer-experimental autoimmune thyroiditis".
Mignon-Godefroy K; Brazillet MP; Rott O; Charreire J
Cell Immunol; 1995 May; 162(2):171-7. PubMed ID: 7743543
[TBL] [Abstract][Full Text] [Related]
17. Long-term observation and effect of age on induction of experimental autoimmune thyroiditis in susceptible and resistant mice.
Okayasu I; Hatakeyama S; Kong YC
Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 1):254-67. PubMed ID: 2791341
[TBL] [Abstract][Full Text] [Related]
18. Synergism between mouse thyroglobulin- and vaccination-induced suppressor mechanisms in murine experimental autoimmune thyroiditis.
Nabozny GH; Flynn JC; Kong YC
Cell Immunol; 1991 Sep; 136(2):340-8. PubMed ID: 1831404
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-12 promotes activation of effector cells that induce a severe destructive granulomatous form of murine experimental autoimmune thyroiditis.
Braley-Mullen H; Sharp GC; Tang H; Chen K; Kyriakos M; Bickel JT
Am J Pathol; 1998 May; 152(5):1347-58. PubMed ID: 9588903
[TBL] [Abstract][Full Text] [Related]
20. Characterization of resistance to murine experimental autoimmune thyroiditis: duration and afferent action of thyroglobulin- and TSH-induced suppression.
Fuller BE; Okayasu I; Simon LL; Giraldo AA; Kong YM
Clin Immunol Immunopathol; 1993 Oct; 69(1):60-8. PubMed ID: 7691454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
